| abstract |
The subject of the application is the use of at least one microRNA selected from the group hsa-let-7b-3p, hsa-miR-106b-3p, hsa-miR-122-5p, hsa-miR-122b-3p, hsa-miR-1250-5p , hsa-miR-1277-3p, hsa-miR-1277-5p, hsa-miR-128-3p, hsa-miR-181a-2-3p, hsa-miR-183-5p, hsa-miR-186-3p , hsa-miR-19a-3p, hsa-miR-206, hsa-miR-208a-3p, hsa-miR-25-3p, hsa-miR-30e-3p, hsa-miR-33a-5p, hsa-miR -454-3p, hsa-miR-497-3p, hsa-miR-548aa, hsa-miR-548ac, hsa-miR-548d-3p, hsa-miR-548d-5p, hsa-miR-548t-3p, hsa -miR-576-3p, hsa-miR-590-3p, hsa-miR-769-5p and hsa-miR-874-5p as a marker for diagnosing chronic venous disease. The invention also relates to a method for diagnosing chronic venous disease. |